Lawley Lori D
Insider CIK 1747716 · (NLNK) Principal Accounting Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 12,000 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 2,776 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 12,000 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 21,250 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 25,000 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 12,000 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 1,282 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 4,628 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer deriv | 2024-12-12 | 2024-12-13 | 10,625 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | D To issuer | 2024-12-12 | 2024-12-13 | 12,284 | — | $0 | 0 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | F Tax w/h | 2024-08-01 | 2024-08-05 | 229 | $1.79 | $410 | 12,284 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award deriv | 2024-04-01 | 2024-04-03 | 12,000 | — | $0 | 12,000 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award | 2024-04-01 | 2024-04-03 | 1,000 | $2.84 | $2.8K | 12,787 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | F Tax w/h | 2024-04-01 | 2024-04-03 | 274 | $2.84 | $778 | 12,513 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | F Tax w/h | 2024-02-01 | 2024-02-05 | 215 | $3.01 | $647 | 11,787 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | F Tax w/h | 2023-08-01 | 2023-08-03 | 229 | $3.28 | $751 | 11,502 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | F Tax w/h | 2023-04-01 | 2023-04-04 | 274 | $3.31 | $907 | 11,231 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award deriv | 2023-02-01 | 2023-02-03 | 12,000 | — | $0 | 12,000 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | F Tax w/h | 2023-02-01 | 2023-02-03 | 114 | $3.52 | $401 | 11,505 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award | 2023-02-01 | 2023-02-03 | 1,000 | $3.52 | $3.5K | 11,619 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | F Tax w/h | 2022-08-01 | 2022-08-03 | 229 | $8.17 | $1.9K | 10,119 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | F Tax w/h | 2022-04-01 | 2022-04-05 | 274 | $9.23 | $2.5K | 9,848 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award deriv | 2022-02-01 | 2022-02-03 | 12,000 | — | $0 | 12,000 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | F Tax w/h | 2022-02-01 | 2022-02-03 | 65 | $10.02 | $651 | 10,122 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award | 2022-02-01 | 2022-02-03 | 1,000 | $10.02 | $10.0K | 10,187 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award deriv | 2021-08-01 | 2021-08-03 | 21,250 | — | $0 | 21,250 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award | 2021-08-01 | 2021-08-03 | 3,750 | — | $0 | 9,187 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | F Tax w/h | 2021-04-01 | 2021-04-05 | 274 | $12.25 | $3.4K | 5,437 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award deriv | 2021-02-01 | 2021-02-03 | 10,625 | — | $0 | 10,625 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award | 2021-02-01 | 2021-02-03 | 869 | — | $0 | 5,711 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award deriv | 2020-04-01 | 2020-04-03 | 25,000 | — | $0 | 25,000 | SEC↗ |
| (LUMO) LUMOS PHARMA, INC. | A Award | 2020-04-01 | 2020-04-03 | 4,500 | — | $0 | 4,842 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | D To issuer deriv | 2019-07-31 | 2019-08-02 | 10,000 | — | $0 | 0 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 1,633 | — | $0 | 1,633 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 868 | — | $0 | 868 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | D To issuer deriv | 2019-07-31 | 2019-08-02 | 2,000 | — | $0 | 0 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 472 | — | $0 | 472 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 98 | — | $0 | 98 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 98 | — | $0 | 98 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 105 | — | $0 | 105 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 187 | — | $0 | 187 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 563 | — | $0 | 563 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 146 | — | $0 | 146 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | D To issuer deriv | 2019-07-31 | 2019-08-02 | 2,000 | — | $0 | 0 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 1,250 | — | $0 | 1,250 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 3,021 | — | $0 | 3,021 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 729 | — | $0 | 729 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | D To issuer deriv | 2019-07-31 | 2019-08-02 | 10,000 | — | $0 | 0 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 360 | — | $0 | 360 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 311 | — | $0 | 311 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 115 | — | $0 | 115 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | D To issuer deriv | 2019-07-31 | 2019-08-02 | 2,352 | — | $0 | 0 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 70 | — | $0 | 70 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 487 | — | $0 | 487 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-07-31 | 2019-08-02 | 1,111 | — | $0 | 1,111 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | D To issuer deriv | 2019-07-31 | 2019-08-02 | 3,334 | — | $0 | 0 | SEC↗ |
| (NLNK) NEWLINK GENETICS CORP | A Award deriv | 2019-03-01 | 2019-03-05 | 50,000 | — | $0 | 50,000 | SEC↗ |